This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The European Medicines Agency said the portal will enable consultations with med...
Relocating manufacturing would require substantial capital investment, but the t...
CEO Tim Herbert told investors the company received a civil investigative demand...
MGB said the layoffs were necessary to get ahead of an anticipated budget shortf...
Gottlieb, who led the agency during the first Trump presidency, supports a rever...
BD announced it would split from its biosciences and diagnostics unit, while Zim...
Caroline Pearson, the executive director of the Peterson Health Technology Insti...
The alert was posted one day after BD sent customers a letter warning about the ...
Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-y...
The company will keep the systems on the market but is asking providers to check...
Analysts said the move comes amid rising trade tensions with the U.S. and as Ill...
Pulse, which named a new CEO last month, is pitching its pulsed field ablation t...
Disruption to the supply of devices from China would curtail hospitals' ability ...
Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed t...
With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, ex...
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulati...
Job cuts in Cambridge and Plainville are the second workforce reduction planned ...
CEO Tom Polen said BD will “double down on shifting our portfolio, both organica...